Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Depreciation & Amortization (CF) (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Depreciation & Amortization (CF) for 5 consecutive years, with $110000.0 as the latest value for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) fell 37.85% year-over-year to $110000.0; the TTM value through Mar 2026 reached $566000.0, down 25.33%, while the annual FY2025 figure was $633000.0, 20.38% down from the prior year.
  • Depreciation & Amortization (CF) hit $110000.0 in Q1 2026 for Phathom Pharmaceuticals, down from $128000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $214000.0 in Q1 2024 and bottomed at $110000.0 in Q1 2026.
  • Average Depreciation & Amortization (CF) over 5 years is $160764.7, with a median of $168000.0 recorded in 2022.
  • Year-over-year, Depreciation & Amortization (CF) surged 60.16% in 2024 and then tumbled 37.85% in 2026.
  • Phathom Pharmaceuticals' Depreciation & Amortization (CF) stood at $168000.0 in 2022, then grew by 10.12% to $185000.0 in 2023, then increased by 4.32% to $193000.0 in 2024, then plummeted by 33.68% to $128000.0 in 2025, then dropped by 14.06% to $110000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $110000.0, $128000.0, and $156000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.